New Zealand is right to pause travel to Australia. It buys time to upgrade...
With the trans-Tasman travel bubble burst, now is the time to upgrade our Covid response against the threat of a Delta variant outbreak. Read more from University of Canterbury's Dr Matt Hobbs in a new article on The Conversation.
The power of peer-to-peer communication in the COVID-19 vaccine rollout: study
During the COVID-19 pandemic, discussions with peers played a large role in people’s decisions around vaccination, new research from UNSW Sydney shows.
Duke Researchers Receive Grant to Roll Out Next-Generation Coronavirus Vaccine
The National Institute of Allergy and Infectious Diseases (NIAID) has awarded $17.5 million over three years to the Duke Human Vaccine Institute to develop a vaccine that protects against multiple types of coronaviruses and viral variants.
Coronavirus Sequencing Leads to Insights on Transmission, Vaccine Development
Source: Graduate School, UW-MadisonBy Meghan Chua
As graduate students at UW–Madison, Katarina Braun and Gage Moreno were already working...
University of Toronto’s 2021-2022 budget to focus on students, provide more supports for equity-deserving...
The University of Toronto plans to make additional investments in student learning, supports and financial aid, as well as boost access for equity-deserving groups and hire more Black and...
Bergman to study COVID-19 economic recovery
Milgard School economic Margo Bergman has been awarded a COVID-19 economic research recovery grant, one of 18 funded by UW's Population Health...
A walk in the park? How spending time in nature can boost mental health
If you’re feeling stressed, anxious or discouraged, finding the energy to get outdoors may be hard – but it could be one of the best things you could do to lift your mood, particularly during COVID-19.
Should a COVID-19 vaccine be mandated?
Now that two drug makers — Pfizer and Moderna — have reported highly effective results for their COVID-19 vaccines, it will be only a matter of time until they seek...
Single dose of Pfizer BioNTech vaccine reduces asymptomatic infections and potential for SARS-CoV-2 transmission
New data from Addenbrooke's Hospital in Cambridge suggests that a single dose of the Pfizer BioNTech vaccine can reduce by 75% the number of asymptomatic SARS-CoV-2 infections.
Global leaders unite for World Evidence-Based Healthcare Day
Seven global leaders in evidence-based healthcare, including the University of Adelaide’s JBI, have joined forces to raise awareness for better evidence to inform healthcare policy...
- Advertisement -
